Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking

Pharmacological and anatomical evidence suggests that abnormal glutamatergic neurotransmission may be associated with the pathophysiology of depression. Compounds that act as NMDA receptor antagonists may be a potential treatment for depression, notably the rapid-acting agent ketamine. The rapid-act...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jin-Gang, Zhou, Hai-Yun, Wang, Fang, Chen, Jian-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140449/
https://www.ncbi.nlm.nih.gov/pubmed/37124348
http://dx.doi.org/10.1016/j.bpsgos.2022.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140449/
https://www.ncbi.nlm.nih.gov/pubmed/37124348
http://dx.doi.org/10.1016/j.bpsgos.2022.02.007

Ejemplares similares